Q3 2024 Holdings
Filed 2024-11-14 | 5 holdings | $153.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris N.V.(PHVS) | COM | N69605108 | $81.4M | 4,397,881 | 53.2% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $36.1M | 1,849,947 | 23.6% |
| Syndax Pharmaceuticals, Inc.(SNDX) | COM | 87164F105 | $16.8M | 875,000 | 11.0% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $11.5M | 8,325,000 | 7.5% |
| Relay Therapeutics Inc.(RLAY) | COM | 75943R102 | $7.1M | 1,000,000 | 4.6% |